AN AUTHORITATIVE GUIDE to THE ACELYRIN CLASS ACTION LAWSUIT

If you suffered losses in ACELYRIN stock, contact ACELYRIN stock loss lawyer Timothy L. Miles about an ACELYRIN class action lawsuit

INTRODUCTION TO THE ACELYRIN CLASS ACTION LAWSUIT

​The ACELYRIN class action lawsuit seeks to represent purchasers or acquirers of ACELYRIN, Inc.  (NASDAQ: SLRN) securities between May 4, 2023 and September 11, 2023 (the “Class Period”). Captioned Aramouni v. ACELYRIN, Inc., No. 23-cv-09672 (C.D. Cal.), the ACELYRIN class action lawsuit charges ACELYRIN and certain of its top current and former executive officers with violations of the​​ Securities Exchange Act of 1934.
​​
If you suffered losses in ACELYRIN stock and wish to serve as lead plaintiff in the ACELYRIN class action lawsuit, please contact ACELYRIN Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the ACELYRIN class action lawsuit must be filed with the court no later than January 16, 2024.

Read on for an authoritative guide on what investors need to know about class actions and the lead plaintiff process in the ACELYRIN class action lawsuit.

the ALLEGATIONS IN THE ACELYRIN CLASS ACTION LAWSUIT

ACELYRIN is a clinical biopharma company that focuses on developing and commercializing transformative medicines.  According to the ACELYRIN class action lawsuit, ACELYRIN’s lead product candidate is izokibep, which is currently in Part B of a Phase 2b/3 clinical trial for use in the treatment of moderate to severe Hidradenitis Suppurativa (“HS”).

The ACELYRIN class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) izokibep was less effective in treating HS than defendants had led investors to believe; (ii) accordingly, ACELYRIN overstated izokibep’s clinical and/or commercial prospects; and (iii) as a result, ACELYRIN also overstated its business prospects post-initial public offering. 

The ACELYRIN class action lawsuit further alleges that on September 11, 2023, ACELYRIN announced disappointing top-line results from Part B of the Phase 2b/3 trial evaluating izokibep for the treatment of moderate-to-severe HS.  Specifically, izokibep failed to show statistically significant reduction in abscesses and inflammatory nodules in patients as compared to placebo, the complaint alleges.  The ACELYRIN class action lawsuit alleges that on this news, the price of ACELYRIN stock fell more than 61% over two trading sessions. ​

WHAT IS THE LEAD PLAINTIFF DEADLINE IN THE ACELYRIN CLASS ACTION LAWSUIT?

​When a securities class action is filed such as the ACELYRIN class action lawsuit, the person who files the first complaint is required to publish a notice announcing the filing. Anyone who wants to be lead plaintiff on behalf of the class in the ACELYRIN class action lawsuit must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published. 

IF you RECEIVEd A SETTLEMENT FROM FINRA you CAN STILL PARTICIPATE IN THE ACELYRIN LAWSUIT

​Yes, the acceptance of restitution or compensation from a FINRA regulatory settlement does not waive your right to monetary or other benefits through the courts, arbitration, or mediation. Therefore, even if you received a settlement from FINRA, you can still participate in the ACELYRIN lawsuit. 

THE LEAD PLAINTIFF PROCESS IN THE ACELYRIN CLASS ACTION LAWSUIT

The Private Securities Litigation Reform Act of 1995 permits any investor who purchased and suffered losses in ACELYRIN stock to seek appointment as lead plaintiff in the ACELYRIN class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. 
​
​A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit.  An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in ACELYRIN stock and have further questions, contact ACELYRIN​ stock loss Lawyer Timothy L. Miles today who will fight to recover your damages in a ACELYRIN class action lawsuit if you suffered losses in ACELYRIN​​ stock.

NON-U.S. INVESTORs can SERVE AS LEAD PLAINTIFFs IN THE ACELYRIN CLASS ACTION LAWSUIT

Courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors.  Thus, if a non-U.S. investor suffered losses in ACELYRIN​​ stock, they may move the Court to be appointed lead plaintiff in the ACELYRIN class action lawsuit. 

THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE ACELYRIN CLASS ACTION LAWSUIT

Serving as a Lead Plaintiff in the ACELYRIN class action lawsuit has several advantages and important benefits including:

• A Lead Plaintiff is able to negotiate more competitive attorney fees and reduce other litigation costs by actively monitoring the class counsel.
• Lead Plaintiff has the benefit of being able to manage the litigation primarily by overseeing and monitoring the progress of the action and the efforts of counsel, and being able to review and comment on important filings and other documents pertaining to the prosecution of the action.
• There is no financial risk in serving as a Lead Plaintiff because Lead Counsel advances all costs and expenses incurred in the prosecution of the case and will be reimbursed only if there is a successful settlement or judgment recovery on behalf of the class.
• Lead Plaintiff has the benefit of being involved and active in all negotiations relating to any settlement.
• Lead Plaintiffs that continue owning the stock of the defendant will enjoy the long-term benefits from governance reform resulting from the litigation. 

Thus, there are numerous benefits and other advantages to serving as lead plaintiff in the ACELYRIN class action lawsuit if you suffered losses in ACELYRIN stock. ​

the RESPONSIBILITIES THE LEAD PLAINTIFF will HAVE IN THE ACELYRIN CLASS ACTION LAWSUIT

​​A Lead Plaintiff owes a fiduciary duty to the class, and therefore, must act in the best interest of the class in the ACELYRIN class action lawsuit.  Some of the responsibilities of the Lead Plaintiff in the ACELYRIN class action lawsuit include:

• Selecting, monitoring, and overseeing Lead Counsel.
• Reviewing and commenting on court filings on behalf of the class.
• Discussing litigation strategies with the Lead Counsel.
• Attending depositions (if necessary) and giving a deposition.
• Attending hearings (if necessary).
• Participating in mediation and the trial (if necessary).
• Provide input on any decision concerning the settlement of the securities class action.

THE LEAD PLAINTIFFS will not GET MORE MONEY THAN CLASS MEMBERS IF THE ACELYRIN CLASS ACTION LAWSUIT SETTLES

However, they may be entitled to recover their reasonable expenses incurred with are directly related to representing the class in the ACELYRIN class action lawsuit. Under the Private Securities Litigation Reform Act of 1995, a Lead Plaintiff is only entitled to his or her pro rata share of any recovery and does not receive any additional money for serving as a representative party on behalf of the class.  However, a court, in its discretion, may approve an award of “reasonable costs and expenses (including lost wages)” to a Lead Plaintiff that directly relates to the representation of the class in the ACELYRIN class action lawsuit on behalf of investors who suffered losses in ACELYRIN​ stock​. 

THE COURT may APPOINT MORE THAN ONE LEAD PLAINTIFF IN THE ACELYRIN LAWSUIT

​At its discretion, the Court may appoint a person, entity, or group of persons and/or entities as Lead Plaintiffs to oversee the ACELYRIN​ lawsuit.

THE CLASS PERIOD DETERMINation IN THE ACELYRIN LAWSUIT

In a securities fraud class action, the class period refers to a period of time in which it is alleged the price of the company’s stock was artificially inflated due to false and misleading statements made by company executives.  The class period starts when the company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading.  The class period ends when the truth is revealed to the investing public through a corrective disclosure.  
 
In order to be a part of the class in the ACELYRIN​ lawsuit, you must have suffered losses in ACELYRIN stock by purchasing during the class period when it is alleged the price of the stock was artificially inflated to be included in the ACELYRIN​ lawsuit​​.  

YOU CAN SELL YOUR STOCK AND STILL BE A MEMBER OF THE CLASS IN THE ACELYRIN CLASS ACTION LAWSUIT

​​Yes. There is no requirement for you to retain ownership of the stock after the class period has expired to participate in the ACELYRIN class action lawsuit.

AN ACELYRIN STOCK LOSS LAWYER CAN HELP YOU

An ACELYRIN stock loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation and focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals such as the ACELYRIN lawsuit. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, they have lost money due to mistakes, incompetence, or fraud by an investment professional.

While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discover every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct. 

Look for a securities lawyer with experience, high ethical standards, verifiable credentials, and a trustworthy reputation among his peers and the judiciary, as well as testimonials from previous clients and awards and recognitions.

One name that immediately pops up is nationally known and widely respected Nashville lawyer Timothy L. Miles, who has valuable experience and has received numerous awards, mostly due to his high ethical standards, and hard work ethic, including most recently being named a Top 25 Class action lawyer by the National Trial Lawyers Association, and has maintained an AV rating from Martindale-Hubble since 2014, was named a 2023 Top Rated Litigator and 2023 Top Rated Lawyer by Martindale-Hubble and ALM, and was recently named a 2023 Elite Lawyer of the South by Martindale-Hubble for the fifth year in a row, and was a recipient of Avvo Client’s Choice Award in 2021, in 2022 was featured in the Top 100 Lawyers Magazine and received the Lifetime Achievement Award by Premier Lawyers of America (2019–2021).

​This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. 

WHEN YOU CAN EXPECT TO RECEIVE A PAYMENT IF THE ACELYRIN CLASS ACTION LAWSUIT SETTLES

​If there is a settlement in the ACELYRIN class action lawsuit, you should receive a court-ordered Notice through the mail which will provide a date when the court will hold a final hearing to decide if it will approve the settlement. If your address changed, you may also find lawsuits through sites such as Consumer Action and ClassAction.org along with instructions on how to submit a claim. The Notice will instruct you what you need to do to file a claim. In some class action settlements, you are automatically submitted and need to do nothing further. However, in others, you may be required to submit more information to proceed such as documentation proving your purchase, such as a receipt or brokerage slip or other evidence that you bought or sold ACELYRIN stock during the class period and suffered losses in ACELYRIN​ stock.
 
The court will hold a final hearing in the ACELYRIN class action lawsuit on a date provided in the Notice to decide whether to finally approve the settlement. If the Court finally approves the settlement, and there are no objections or appeals, settlement payments will be mailed to all Participating Class Members within a few months. However, if there are objections or appeals, resolving them can take a significant amount of time, perhaps more than a year to resolve the ACELYRIN ​lawsuit. ​

You have the right to object if there is a settleement in the ACELYRIN CLASS ACTION LAWSUIT AND you DO NOT THINK IT IS FAIR

​If you receive a notice that the ACELYRIN class action lawsuit has been settled and you do not believe the settlement is fair but do not want to opt-out and file your own lawsuit, you may object to the settlement. You may object to any part of the settlement and the Court will consider all timely filed objections in the class action against ACELYRIN. The notice will contain the date when any objections must be filed and include instructions on where to send your objection and include a date for the final hearing in the  ACELYRIN class action lawsuit if you would like to appear and be heard by the court in the class action against ACELYRIN​​.

THE DIFFERENCE BETWEEN OBJECTING AND EXCLUDING yourSELF IN THE ACELYRIN CLASS ACTION LAWSUIT

​Objecting is telling the Court you do not believe the settlement in the ACELYRIN class action lawsuit, or some part of it, is fair or reasonable.  You can file an objection only if you stay in the Class and do not exclude yourself, and you may submit a Claim Form even if you object to the settlement.  On the other hand, requesting exclusion is explicitly telling the Court you do not want to be part of the Class or the Settlement in the class action against ACELYRIN. If you exclude yourself, you cannot object to the Settlement because you no longer have standing as you are not a class member anymore. Similarly, you cannot submit a Claim Form. If you stay in the Class and object, but your objection is overruled, you will not be allowed a second opportunity to exclude yourself.

CONTACT AN ACELYRIN STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN ACELYRIN STOCK ABOUT AN ACELYRIN CLASS ACTION LAWSUIT

If you suffered losses in ACELYRIN stock, contact ACELYRIN stock loss lawyer Timothy L. Miles today for a free case evaluation about an ACELYRIN class action lawsuit. Call today and see what an ACELYRIN stock loss lawyer could do for you if you suffered losses in ACELYRIN​ stock. ​This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. ​

ACELYRIN stock loss lawyer Timothy L. Miles

Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator, and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, Class Action:  Class Action: Top 100 National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM  (2019-2022); America's Most Honored Lawyers 2020; Top 1% by America's Most Honored (2020-2022).  Mr. Miles has published over three hundred articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more.  Please visit our website or Resources center and call for free anytime.

CONTACT                                                      
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846-6529